Speaker Faculty

Hakim Bouterfa

Co-Founder & Managing Director

PentixaPharm GmbH

Andreas Kluge

General Manager

ABX-CRO

Martin Treder

Chief Scientific Officer

ARJUNA Therapeutics

Urs Hagemann

Head of Laboratory & Project Manager

Bayer

Sheamus Gleason

Executive Vice President

Clarity Pharmaceuticals

Andrew (Andy) Simmons

Vice President - Translational Medicine

Clovis Oncology

Jan van Bodegom

Chief Executive Officer

Coretag

Evren Atlihan Gundogdu

Associate Professor

Ege University

Natalie Grinshtein

Director – Research

Fusion Pharmaceuticals

Gareth Smith

General Manager, Europe

ImaginAb

Amir Jalilian

Technical Officer & Professor – Radiopharmacy

International Atomic Energy Agency

Francesco Giammarilo

Senior Technical Officer

International Atomic Energy Agency

Jean-Francois

Gestin Founder

Isotope4life

Sarah Cheal

Sr Research Scientist

Memorial Sloan Kettering Cancer Center

Chris Pak

Chief Executive Officer & President

Molecular Targeting Technologies

Dana Niculae

Head Of Radiopharmaceutical Research Centre Horia Hulubei

National Institute of Physics and Nuclear Engineering - IFIN-HH

Jostein Dahle

Chief Scientific Officer

Nordic Nanovector

Cyril Berthet

Director - Pharmaco-Imaging Unit & Discovery Program

Oncodesign SA

Michael Hofman

Director - Prostate Cancer Theranostics & Imaging Centre of Excellence

Peter MacCallum Cancer Centre

Ludovic Le Meunier

Deputy CEO & Head of Medical Systems

PMB

Tony Lahoutte

Chief Science Officer P

recirix

Markus Luster

Professor & Nuclear Medicine Specialist

Philipps-Universität Marburg

James Nagarajah

Assistant Professor

Radboudumc

Steven Deitcher

President, Chief Executive Officer & Board Member

Radimmune

Marcus Kelly

Associate Director - Oncology & Angiogenesis

Regeneron Pharmaceuticals

Laura Ravasi

Head of Global Medical Affairs

Telix Pharmaceuticals

Christine Merkel

Associate Director of Research & Policy

The Health Policy Partnership

Ken Song

Chief Executive Officer

Rayze BIO

Alexander McEwan

Professor Emeritus

University of Alberta, Department of Oncology

Marian Meckel

Head Of Research And Development

ITM